Development of acute gouty attack in the morbidly obese population after bariatric surgery.
BACKGROUND
Gout is associated with increased body weight. We evaluated the prevalence of gout and acute gouty attacks in the morbidly obese population who underwent bariatric surgery.


METHODS
The medical records and operative reports of 1,240 patients who underwent bariatric surgery were reviewed retrospectively for weight parameters, BMI, weight loss, medical history of gout, and onset of acute gouty attacks.


RESULTS
Of the 1,240 patients, 5 (0.4%) had been previously diagnosed with gout. 2 of these 5 had acute attacks during the postoperative period, and responded successfully to intravenous colchicine.


CONCLUSIONS
Although rare, gout must be considered a co-morbid illness in obese and morbidly obese patients. Surgeons should be familiar with the signs and symptoms of attacks in the postoperative period, and be knowledgeable in the management.
Antozzi
Priscila
P
Bariatric Institute, Section of Minimally Invasive Surgery, Cleveland Clinic Florida, Weston, FL 33331, USA.
Soto
Flavia
F
Arias
Fernando
F
Carrodeguas
Lester
L
Ropos
Trumane
T
Zundel
Natan
N
Szomstein
Samuel
S
Rosenthal
Raul
R
D000208:Acute Disease; D000328:Adult; D000368:Aged; D049088:Bariatrics; D015992:Body Mass Index; D001835:Body Weight; D003078:Colchicine / Q000008:administration & dosage / Q000627:therapeutic use; D006073:Gout / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D006074:Gout Suppressants / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000601:surgery*; D012189:Retrospective Studies; D013997:Time Factors; D015431:Weight Loss
D006074:Gout Suppressants; D003078:Colchicine